MedPath

VIETLIFE HEALTHCARE CORPORATION

🇻🇳Vietnam
Ownership
Private
Employees
-
Market Cap
-
Website

CH1701 for Prevention and Treatment of Radiation Burns

Phase 1
Conditions
Cancer
Interventions
Drug: Safety assessment of CH1701
Drug: CH1701 for prevention and treatment of radiation burns.
Drug: Placebos
First Posted Date
2020-05-13
Last Posted Date
2020-08-24
Lead Sponsor
Vietlife Healthcare Corporation
Target Recruit Count
92
Registration Number
NCT04386343
Locations
🇻🇳

Vietlife Healthcare Corporation, Hanoi, Vietnam

© Copyright 2025. All Rights Reserved by MedPath